None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Healthy subjects: Do not have any psychiatric disorders currently, nor have had similar disorders in the past Able to understand an explanatory document and give consent Patients: Patients in depressive state. Able to understand an explanatory document and give consent
Exclusion criteria
Exclusion criteria: Healthy subjects: Pregnant or possible to become pregnant Currently breastfeeding Have a cardiac pacemaker or other metals in the body, such as brain clip or bolt Participating in other studies involving the use of nuclear medicine within the past 6 months, in terms of radiation safety Other: judged inappropriate as a subject by the investigator Patients: Severe suicidal tendency Presence of other comorbid psychiatric disorders Have taken antidepressants and/or antipsychotic drugs within 1 month prior to the first examination Have organic brain diseases Have current severe physical diseases Pregnant or possible to become pregnant Currently breastfeeding Have a cardiac pacemaker or other metals in the body, such as brain clip or bolt Other: judged inappropriate as a subject by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of polymorphism of monoamine-related molecule in patients with depression and healthy volunteers corresponding to change in PET/MRI data and symptom. | — |
Countries
Japan